Steven Pavletic, MD, MS, from the National Cancer Institute, Bethesda, MD, gives an overview of the management of chronic graft-versus-host disease (GvHD) from the European Society for Blood and Marrow Transplantation (EBMT) 2018 Annual Meeting, held in Lisbon, Portugal.
